Autopsy report · NCT03003273
Early Stoppage Versus Continuation of Antimicrobial Therapy in Low Risk Pediatric Cancer Patients With Febrile Neutropenia, Before Recovery of Counts: -DALFEN Study
Cause of deathSlow enrollment
“poor accrual”
Life of this trial
- Registered 1 month before it started.
- Ran for about 1 year 11 months before it stopped.
- 142 participants planned (an estimate, not an actual count).
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 3
- Sponsor
- All India Institute of Medical Sciences
- Sponsor type
- University, hospital or other
- Conditions
- Neutropenia, Febrile; Pediatric Cancer
- Interventions
- stoppage of antibiotics; amoxycillin/clavulanic acid; levofloxacin
- Participants
- 142 (planned, not actual)
- Sites
- 1
- Countries
- India
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.